Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today
Showing 13 studiesSortNewest indexed ▾
B
grade
Nursing intensity trajectory patterns and clinical outcomes in intensive care units: a latent class analysis.
Lypressin · International journal of nursing studies advances · 2026 · Observational · n=7334
Distinct nursing intensity patterns in ICU patients correlate with mortality and length of stay, but further research is needed to apply these findings clinically.
Rapid Improvement associated with 74% lower mortality odds (OR = 0.26, 95% CI: 0.18-0.36, p < 0.001).
C
grade
Integrated Phytochemical Characterisation, Pharmacological Evaluation and Computational Investigation of &lt;i&gt;Acampe papillosa&lt;/i&gt; Stem Extract.
Lypressin · Analytical science advances · 2026 · Animal study · PreclinicalHigh-impact journal
Acampe papillosa stem extract shows promising pharmacological effects in rodents, but human studies are needed to confirm its potential as a treatment for anxiety, inflammation, and fever.
Rectal temperature reduced to 98.04 ± 0.05°F at 21 h post-treatment.
B
grade
Poor sleep quality and its association patterns with eating disorders, body composition and physical activity among university students in Douala-Cameroon.
Lypressin · IBRO neuroscience reports · 2026 · Observational · n=522
Poor sleep is common among university students and is linked to higher risk of eating disorders and changes in body composition. Addressing sleep quality could be important for student health.
73.7% prevalence of poor sleep quality among students.
B
grade
MedFusion-gP-AKI: development and multicenter validation of a machine learning fusion model for early prediction of KDIGO stage 3 acute kidney injury in critically ill traumatic cervicothoracic spinal cord injury patients.
Lypressin · Renal failure · 2026 · Observational · n=188
The MedFusion-GP-AKI model achieved an AUC of 0.938 for predicting severe AKI in critically ill TCTSCI patients, indicating strong predictive performance.
AUC of 0.938 for model performance.
B
grade
Prognostic value of stress hyperglycemia ratio in critically Ill patients with acute kidney injury: a machine learning-driven retrospective cohort analysis.
Lypressin · Health information science and systems · 2023 · Observational · n=5555
Higher stress hyperglycemia ratios are linked to increased mortality risk in critically ill patients with acute kidney injury, according to a study of 5,555 ICU patients.
HR > 1, p < 0.01 for both 30-day and 90-day mortality.
C
grade
Treatment with low-dose bicistronic immunotherapy mitigates parasite persistence and improves serological and cardiac outcomes in adult mice infected with &lt;i&gt;Trypanosoma cruzi&lt;/i&gt;: comparative analysis with benznidazole.
Lypressin · Emerging microbes & infections · 2026 · Observational · Preclinical
Bicistronic immunotherapy showed over 95% control of parasite burden in mice infected with Trypanosoma cruzi, outperforming benznidazole in reducing inflammation and cardiac pathology.
Treatment with BCV, BCVR or BZN achieved >95% control of parasite burden.
B
grade
Elevated atherogenic index of plasma is associated with severe acute kidney injury in critically ill patients with cardiovascular disease - a MIMIC-IV analysis with external validation in the eICU-CRD database.
Lypressin · Renal failure · 2026 · Observational · n=5872
Elevated atherogenic index of plasma is associated with increased risk of severe acute kidney injury and renal replacement therapy in critically ill patients, but further prospective studies are needed to confirm these findings.
Adjusted OR for high AIP associated with stage 3 AKI was 1.35 (95% CI: 1.11-1.64)
Showing 13 of 13